Cytogenetics of Leukemia

References

• Heim S, Mitelman F. Primary chromosome abnormalities in human neoplasia. Adv Cancer Res 1989; 52: 1–43
   PubMed Web of Science ®Google Scholar
• Heim S, Mitelman F. Secondary chromosome aberrations in the acute leukemias. Cancer Genet Cytogenet 1986; 22: 331–338
   PubMed Web of Science ®Google Scholar
• Rowley J D. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 290–293
   PubMed Web of Science ®Google Scholar
• De Braekeleer M. Variant Philadelphia translocations in chronic myeloid leukemia. Cytogenet Cell Genet 1987; 44: 215–222
   PubMedGoogle Scholar
• Van der Plas D C, Grosveld G, Hagemeijer A. Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML. Cancer Genet Cytogenet 1991; 52: 143–156
   PubMed Web of Science ®Google Scholar
• Kantarjian H M, Deisseroth A, Kurzrock R, et al. Chronic myelogenous leukemia: A concise update. Blood 1993; 82: 691–703
   PubMed Web of Science ®Google Scholar
• First International Workshop. on Chromosomes in Leukaemia 1977: Chromosomes in Ph'-positive chronic granulocytic leukaemia. Br J Haematol 1978; 39: 305–310
   PubMed Web of Science ®Google Scholar
• Groffen J, Stephenson J R, Heisterkamp N, et al. Philadelphia chromosomal breakpoints are clustered with a limited region, bcr, on chromosome 22. Cell 1984; 36: 93–99
   PubMed Web of Science ®Google Scholar
• Heisterkamp N, Stam K, Groffen J, et al. Structural organization of the bcr gene and its role in the Ph' translocation. Nature 1985; 315: 758–761
   PubMed Web of Science ®Google Scholar
• Shtivelman E, Lifshitz B, Gale R P, et al. Fused transcripts of abl and bcr genes in chronic myelogenous leukaemia. Nature 1985; 315: 550–554
   PubMed Web of Science ®Google Scholar
• Grosveld G, Verwoerd T, Van Agthoven T, et al. The chronic myelocytic cell line K562 contains a breakpoint in bcr and produces a chimeric bcr/c-abl transcript. J Mol Cell Biol 1986; 6: 607–616
   Web of Science ®Google Scholar
• Gale R P, Goldman J M. Rapid progress in chronic myelogenous leukemia. Leukemia 1988; 2: 321–324
   PubMed Web of Science ®Google Scholar
• Travis L B, Pierre R V, Dewald G W. Ph'-negative chronic granulocytic leukemia: A nonentity. Am J Clin Pathol 1986; 85: 186–193
   PubMed Web of Science ®Google Scholar
• Yunis J J, Lobell M, Arnesen M A, et al. Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia. Br J Haematol 1988; 68: 189–194
   PubMed Web of Science ®Google Scholar
• Fourth International Workshop on Chromosomes in Leukemia. A prospective study of acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1984; 11: 249–360
   PubMed Web of Science ®Google Scholar
• Marosi C, Köller U, Koller-Weber E, et al. Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AML. Cancer Genet Cytogenet 1992; 61: 14–25
   PubMed Web of Science ®Google Scholar
• Heim S, Bekassy A N, Garzicz S, et al. Bone marrow karyotypes in 94 children with acute leukemia. Eur J Haematol 1990; 44: 227
   PubMed Web of Science ®Google Scholar
• Heinonen K, Rautonen J, Slimes M A, et al. Cytogenetic study of 105 children with acute lymphoblastic leukemia. Eur J Haematol 1988; 41: 237–242
   PubMed Web of Science ®Google Scholar
• Prigogina E L, Puchkova G P, Mayakova S A. Nonrandom chromosomal abnormalities in acute lymphoblastic leukemia of childhood. Cancer Genet Cytogenet 1988; 32: 183–203
   PubMed Web of Science ®Google Scholar
• Third International Workshop on Chromosomes in Leukemia. 1980: Clinical significance of chromosomal abnormalities in acute lymphoblastic leukemia. Cancer Genet Cytogenet 1981; 4: 111–137
   PubMed Web of Science ®Google Scholar
• Group Francais de Cytogenetique Hematologique. Collaborative study of karyotypes in childhood acute lymphoblastic leukemias. Leukemia 1993; 7: 10–19
   PubMed Web of Science ®Google Scholar
• Bennett J M, Catovsky D, Daniel M T, et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 626–629
   PubMedGoogle Scholar
• Heim S. Numerical chromosome aberrations in human neoplasia. Cancer Genet Cytogenet 1986; 22: 99–108
   PubMed Web of Science ®Google Scholar
• Hagemeijer A, Hahlen K, Abels J. Cytogenetic follow-up of patients with nonlymphocytic leukemia. II. Acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1981; 3: 109–124
   PubMed Web of Science ®Google Scholar
• Fenaux P, Preudhomme C, Lai J L, et al. Cytogenetics and their prognostic value in de novo acute myeloid leukaemia: a report on 283 cases. Br J Haematol 1989; 73: 61–67
   PubMed Web of Science ®Google Scholar
• Berger R, Flandrin G, Bernheim A, et al. Cytogenetic studies on 519 consecutive de novo acute nonlymphocytic leukemias. Cancer Genet Cytogenet 1987; 29: 9–21
   PubMed Web of Science ®Google Scholar
• Mitelman F, Heim S. Quantitative acute leukemia cytogenetics. Genes Chromos Cancer 1992; 5: 57–66
   PubMed Web of Science ®Google Scholar
• Heim S, Mitelman F. Cancer Cytogenetics, 2nd ed. Wiley-Liss, New York 1995
   Google Scholar
• Schiffer C A, Lee E J, Tomiyasu T, et al. Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia. Blood 1989; 73: 263–270
   PubMed Web of Science ®Google Scholar
• Dewald G W, Schad C R, Lilla V C, et al. Frequency and photographs of HGM11 chromosome anomalies in bone marrow samples from 3,996 patients with malignant hematologic neoplasms. Cancer Genet Cytogenet 1993; 68: 60–69
   PubMed Web of Science ®Google Scholar
• Swansbury G J, Lawler S D, Alimena G, et al. Long-term survival in acute myelogenous leukemia: A second follow-up of the Fourth International Workshop on Chromosomes in Leukemia. Cancer Genet Cytogenet 1994; 73: 1–7
   PubMed Web of Science ®Google Scholar
• Cortes J E, Kantarjian H, O'Brien S, et al. Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromes. Leukemia 1995; 9: 115–117
   PubMed Web of Science ®Google Scholar
• Mitelman F, Kaneko Y, Trent J. Report of the committee on chromosome changes in neoplasia. Cytogenet Cell Genet 1991; 58: 1053–1079
   Google Scholar
• Sreekantaiah C, Baer M R, Morgan S, et al. Trisomy/tetrasomy 13 in seven cases of acute leukemia. Leukemia 1990; 4: 781–785
   PubMed Web of Science ®Google Scholar
• Cuneo A, Ferrant A, Michaux J L, et al. Cytogenetic profile of minimally differentiated (FAB MO) acute myeloid leukemia: correlation with clinicobiologic findings. Blood 1995; 85: 3688–3694
   PubMed Web of Science ®Google Scholar
• Le Beau M M, Albain K S, Larson R A, et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodys-plastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 1986; 4: 325–345
   PubMed Web of Science ®Google Scholar
• Pedersen-Bjergaard J, Philip P, Larsen S O, et al. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia 1993; 12: 1975–1986
   Google Scholar
• Samuels B L, Larson R A, Le Beau M M, et al. Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo. Leukemia 1988; 2: 79–83
   PubMed Web of Science ®Google Scholar
• Nimer S D, Golde D W. The 5q- abnormality. Blood 1987; 70: 1705–1712
   PubMed Web of Science ®Google Scholar
• Boultwood J, Lewis S, Wainscoat J S. The 5q- syndrome. Blood 1994; 84: 3253–3260
   PubMed Web of Science ®Google Scholar
• Grignani F, Fagioli M, Alcalay M, et al. Acute promyelocytic leukemia: from genetics to treatment. Blood 1994; 83: 10–25
   PubMed Web of Science ®Google Scholar
• Licht J D, Chomienne C, Goy A, et al. Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11; 17). Blood 1995; 85: 1083–1094
   PubMed Web of Science ®Google Scholar
• Petkovic I, Konja J, Nakic M. Cytogenetic analysis in children with acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1992; 58: 155–159
   PubMed Web of Science ®Google Scholar
• Alcalay M, Zangrilli D, Pandolfi P P, et al. Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor a locus. Proc Natl Acad Sci USA 1991; 88: 1977–1981
   PubMed Web of Science ®Google Scholar
• Borrow J, Goddard A D, Sheer D, et al. Molecular analysis of acute promyelocytic leukemia breakpoint. Science 1990; 249: 1577–1580
   PubMed Web of Science ®Google Scholar
• De The H, Chomienne C, Lanotte M, et al. The t(15;17) translocation of acute promyelocytic leukaemia. Nature 1990; 347: 558–561
   PubMed Web of Science ®Google Scholar
• Kamada N, Okada K, Oguma N, et al. C-G translocation in acute myelocytic leukemia with low neutrophil alkaline phosphatase activity. Cancer 1976; 37: 2380–2387
   PubMed Web of Science ®Google Scholar
• Sandberg A A. The Chromosomes in Human Cancer and Leukemia. Elsevier Science Publishers, New York 1980
   Google Scholar
• Hurwitz C A, Raimondi S C, Head D, et al. Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblasts leukemia in children. Blood 1992; 80: 3182–3188
   PubMed Web of Science ®Google Scholar
• Tallman M S, Hakimian D, Shaw J M, et al. Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia. J Clin Oncol 1993; 11: 690–697
   PubMed Web of Science ®Google Scholar
• Raimondi S C, Kalwinsky D K, Hayashi Y, et al. Cytogenetics of childhood acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1989; 40: 13–27
   PubMed Web of Science ®Google Scholar
• Berger R, Bernheim A, Daniel M-T, et al. Cytologic characterization and significance of normal karyotypes in t(8;21) acute myeloblasts leukemia. Blood 1982; 59: 171–178
   PubMed Web of Science ®Google Scholar
• Groupe Francais de Cytogenetique Hematologique. Acute myelogenous leukemia with an 8;21 translocation. A report on 148 cases from the Groupe Francais de Cytogenetique Hematologique. Cancer Genet Cytogenet 1990; 44: 169–179
   PubMed Web of Science ®Google Scholar
• Martinez-Climent J A, Lane N J, Rubin C M, et al. Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo. Leukemia 1995; 9: 95–101
   PubMed Web of Science ®Google Scholar
• Erickson P, Gao J, Chang K-S, et al. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 1992; 80: 1825–1831
   PubMed Web of Science ®Google Scholar
• Roulston D, Nucifora G, Dietz-Band J, et al. Detection of rare 21q22 translocation breakpoints within the AML1 gene in myeloid neoplasms by fluorescence in situ hybridization. Blood 1993; 82: 532a, (abstract)
   Web of Science ®Google Scholar
• Romana S P, Mauchauffe M, Le Coniat M, et al. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 1995; 85: 3662–3670
   PubMed Web of Science ®Google Scholar
• Larson R A, Williams S F, Le Beau M M, et al. Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis. Blood 1986; 68: 1242–1249
   PubMed Web of Science ®Google Scholar
• Bernard P, Dachary D, Reiffers J, et al. Acute nonlymphocytic leukemia with marrow eosinophilia and chromosome 16 abnormality: A report of 18 cases. Leukemia 1989; 3: 740–745
   PubMed Web of Science ®Google Scholar
• Campbell L J, Challis J, Fok T, et al. Chromosome 16 abnormalities associated with myeloid malignancies. Genes Chromos Cancer 1991; 3: 55–61
   PubMed Web of Science ®Google Scholar
• Le Beau M M, Larson R A, Bitter M A, et al. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association. N Engl J Med 1983; 309: 630–636
   PubMed Web of Science ®Google Scholar
• Liu P, Tarle S A, Hajra A, et al. Fusion between transcription factor CBF-beta/PEBP2-beta and a myosin heavy chain in acute myeloid leukemia. Science 1993; 261: 1041–1044
   PubMed Web of Science ®Google Scholar
• Redondo J M, Pfohl J L, Hernandez-Munain C, et al. Indistinguishable nuclear factor binding to functional core sites of the T cell receptor 8 and murine leukemia virus enhancers. Mol Cell Biol 1992; 12: 4817–4823
   PubMed Web of Science ®Google Scholar
• Nuchprayoon I, Meyers S, Scott L M, et al. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2β7 CBFβ proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol Cell Biol 1994; 14: 5558–5568
   PubMed Web of Science ®Google Scholar
• Felix C A, Hosier M R, Winick N J, et al. ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children. Blood 1995; 85: 3250–3256
   PubMed Web of Science ®Google Scholar
• Corral J, Forster A, Thompson S, et al. Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation. Proc Natl Acad Sci USA 1993; 90: 8538–8542
   PubMed Web of Science ®Google Scholar
• Hunger S P, Tkachuk D C, Amylon M D, et al. HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities. Blood 1993; 81: 3197–3203
   PubMed Web of Science ®Google Scholar
• Sait S NJ, Raimondi S C, Look A T, et al. A t(11;12) 11q23 leukemic breakpoint that disrupts the MLL gene. Genes Chromos Cancer 1993; 7: 28–31
   PubMed Web of Science ®Google Scholar
• Thirman M J, Gill H J, Burnett R C, et al. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med 1993; 329: 909–914
   PubMed Web of Science ®Google Scholar
• Raimondi S C, Peiper S C, Kitchingman G R, et al. Childhood acute lymphoblastic leukemia with chromosomal breakpoints at 11q23. Blood 1989; 73: 1627–1634
   PubMed Web of Science ®Google Scholar
• Cimino G, Nakamura T, Gu Y, et al. An altered 11-kilobase transcript in leukemic cell lines with the t(4;11)(q21;q23) chromosome translocation. Cancer Res 1992; 52: 33811–33813
   Google Scholar
• Mitelman F. Catalog of Chromosome Aberrations in Cancer, 5th ed. Wiley-Liss, New York 1994
   Google Scholar
• Ludwig W-D, Bartram C R, Ritter J, et al. Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis. Blood 1988; 71: 1518–1528
   PubMed Web of Science ®Google Scholar
• Cuneo A, Ferrant Z, Michaux J-L, et al. Clinical review on features and cytogenetic patterns in adult acute myeloid leukemia with lymphoid markers. Leuk Lymphoma 1993; 9: 285–291
   PubMed Web of Science ®Google Scholar
• Raimondi S C, Peiper S C, Kitchingman G R, et al. Childhood acute lymphoblastic leukemia with chromosomal breakpoints at 11q23. Blood 1989; 73: 1627–1634
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Maseki N, Takasaki N B, et al. Clinical and hematologic characteristics in acute leukemia with 11q23 translocations. Blood 1986; 67: 484–491
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Shikano T, Maseki N, et al. Clinical characteristics of infant acute leukemia with or without 11q23 translocations. Leukemia 1988; 2: 672–676
   PubMed Web of Science ®Google Scholar
• Tkachuk D C, Kohler S, Cleary M L. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 1992; 71: 691–700
   PubMed Web of Science ®Google Scholar
• Tse W, Zhu W, Chen H S, et al. A novel gene AF1q, fused to MLL in t(1;11)(q21;q23), is specifically expressed in leukemic and immature hematopoietic cells. Blood 1995; 85: 650–656
   PubMed Web of Science ®Google Scholar
• Iida S, Seto M, Yamamoto K, et al. MLLT3 gene on 9p22 involved in t(9;11) leukemia encodes a serine/proline rich protein homologous to MLLT1 on 19p13. Oncogene 1993; 8: 3085–3092
   PubMed Web of Science ®Google Scholar
• Pui C-H, Behm F G, Raimondi S C, et al. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N Engl J Med 1989; 321: 136–142
   PubMed Web of Science ®Google Scholar
• Smith M A, Rubinstein L, Ungerleider R S. Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: Estimating the risks. Med Piediatr Oncol 1994; 23: 86–98
   PubMed Web of Science ®Google Scholar
• Sandoval C, Pui C-H, Bowman L C, et al. Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation. J Clin Oncol 1993; 11: 1039–1045
   PubMed Web of Science ®Google Scholar
• Bloomfield C D, Goldman A I, Alimena G, et al. Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. Blood 1986; 67: 415–420
   PubMed Web of Science ®Google Scholar
• Bloomfield C D, Seeker-Walker L M, Goldman A I, et al. Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia. Cancer Genet Cytogenet 1989; 40: 171–185
   PubMed Web of Science ®Google Scholar
• Third International Workshop on Chromosomes in Leukemia. (1980): Chromosomal abnormalities in acute lymphoblastic leukemia. Cancer Genet Cytogenet 1981; 4: 101–111
   PubMed Web of Science ®Google Scholar
• Seeker-Walker L M, Lawler S D, Hardisty R M. Prognostic implications of chromosomal findings in acute lymphoblastic leukaemia at diagnosis. Br Med J 1978; 2: 1529–1530
   PubMed Web of Science ®Google Scholar
• Heerema N A, Palmer C G, Baehner R L. Karyotypic and clinical findings in a consecutive series of children with acute lymphocytic leukemia. Cancer Genet Cytogenet 1985; 17: 165–179
   PubMed Web of Science ®Google Scholar
• Seeker-Walker L M, Chessells J M, Stewart E L, et al. Chromosomes and other prognostic factors in acute lymphoblastic leukaemia: A long-term follow-up. Br J Haematol 1989; 72: 336–342
   PubMed Web of Science ®Google Scholar
• Williams D L, Tsiatis A, Brodeur G M, et al. Prognostic importance of chromosome number in 136 untreated children with acute lymphoblastic leukemia. Blood 1982; 60: 864–871
   PubMed Web of Science ®Google Scholar
• Seeker-Walker L M. Prognostic and biological importance of chromosome findings in acute lymphoblastic leukemia. Cancer Genet Cytogenet 1990; 49: 1–13
   PubMed Web of Science ®Google Scholar
• Groupe Francais de Cytogenetique Hematologique. Collaborative study of karyotypes in childhood acute lymphobblastic leukemias. Leukemia 1993; 7: 10–19
   PubMed Web of Science ®Google Scholar
• Raimondi S C. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 1993; 81: 2237–2251
   PubMed Web of Science ®Google Scholar
• Pui C-H, Raimondi S C, Dodge R K, et al. Prognostic importance of structural chromosomal abnormalities in children with hyper-diploid (50 chromosomes) acute lymphoblastic leukemia. Blood 1989; 73: 1963–1967
   PubMed Web of Science ®Google Scholar
• Crist W, Carroll A, Shuster J, et al. Philadelphia chromosome positive childhood acute lymphoblastic leukemia: Clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study. Blood 1990; 76: 489–494
   PubMed Web of Science ®Google Scholar
• Ribeiro R C, Pui C-H. Prognostic factors in childhood acute lymphoblastic leukemia. Heme Pathol 1993; 7: 121–142
   PubMed Web of Science ®Google Scholar
• Pui C-H, Carroll A J, Raimondi S C, et al. Clinical presentation, karyotypic characterization, and treatment outcome of childhood acute lymphoblastic leukemia with near-haploid or hypodiploid > 45 line. Blood 1990; 75: 1170–1177
   PubMed Web of Science ®Google Scholar
• Brodeur G M, Williams D L, Look A T, et al. Near-haploid acute lymphoblastic leukemia: A unique subgroup with a poor prognosis?. Blood 1981; 58: 14–19
   PubMed Web of Science ®Google Scholar
• Leder P, Battey J, Lenoir G, et al. Translocations among antibody genes in human cancer. Science 1983; 222: 765–770
   PubMed Web of Science ®Google Scholar
• Croce C M, Erikson J, Haluska F G, et al. Molecular genetics of human B- and T-cell neoplasia. Cold Spring Harb Symp 1986; 51: 891–898
   PubMedGoogle Scholar
• Korsmeyer S J. Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. Ann Rev Immunol 1992; 10: 785–807
   PubMed Web of Science ®Google Scholar
• Cairo M S, Krailo M, Hutchinson R, et al. Results of a phase II trial of “French” (F) (LMB-86) or “Orange” (O) (CCG-Hybrid) in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: an improvement in survival. Proc ASCO 1994; 13: 392, (abstract)
   Google Scholar
• Rabbitts T H. Chromosomal translocations in human cancer. Nature 1994; 372: 143–149
   PubMed Web of Science ®Google Scholar
• Pui C-H, Williams D L, Roberson P K, et al. Correlation of karyotype and immunophenotype in childhood acute lymphoblastic leukemia. J Clin Oncol 1988; 6: 56–61
   PubMed Web of Science ®Google Scholar
• Uckun F M, Gajl-Peczalska K J, Provisor A L, et al. Immunophenotype-karyotype associations in human acute lymphoblastic leukemia. Blood 1989; 73: 271–280
   PubMed Web of Science ®Google Scholar
• Pui C-H, Behm F G, Singh B, et al. Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia. Blood 1990; 75: 174–179
   PubMed Web of Science ®Google Scholar
• Carroll A J, Crist W M, Link M P, et al. The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: A Pediatric Oncology Group study. Blood 1990; 76: 1220–1224
   PubMed Web of Science ®Google Scholar
• Finger L R, Kagan J, Christopher G, et al. Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc Natl Acad Sci USA 1989; 86: 5039–5043
   PubMed Web of Science ®Google Scholar
• Begley C G, Apian P D, Davey M P, et al. Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor 5-chain diversity region and results in a previously unreported fusion transcript. Proc Natl Acad Sci USA 1989; 86: 2031–2035
   PubMed Web of Science ®Google Scholar
• Bash R O, Hall S, Timmons C F, et al. Does activation of the TALI gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A Pediatric Oncology Group study. Blood 1995; 86: 666–676
   PubMed Web of Science ®Google Scholar
• Apian P D, Lombardi D P, Ginsberg A M, et al. Disruption of the human SCL locus by “illegitimate” V-(D)-J recombinase activity. Science 1990; 250: 1426–1429
   PubMed Web of Science ®Google Scholar
• Pui C-H, Raimondi S C, Hancock M L, et al. Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19)(q23;p13) or its derivative. J Clin Oncol 1994; 12: 2601–2606
   PubMed Web of Science ®Google Scholar
• Fletcher J A, Lynch E A, Kimball V M, et al. Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia. Blood 1991; 77: 435–439
   PubMed Web of Science ®Google Scholar
• Kurzrock R, Gutterman J U, Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med 1988; 319: 990–998
   PubMed Web of Science ®Google Scholar
• Clark S S, McLaughlin J, Timmons M, et al. Expression of a distinctive BCR-ABL oncogene in Phi-positive acute lymphocytic leukemia (ALL). Science 1988; 239: 775–777
   PubMed Web of Science ®Google Scholar
• Suryanarayan K, Hunger S P, Kohler S, et al. Consistent involvement of the BCR gene by 9;22 breakpoints in pediatric acute leukemias. Blood 1991; 77: 324–330
   PubMed Web of Science ®Google Scholar
• Pui C-H, Frankel L S, Carroll A J, et al. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): A collaborative study of 40 cases. Blood 1991; 77: 440–447
   PubMed Web of Science ®Google Scholar
• Schardt C, Ottmann O G, Hoelzer D, et al. Acute lymphoblastic leukemia with the (4;11) translocation: combined cytogenetic, immunlogical and molecular genetic analyses. Leukemia 1992; 6: 370–374
   PubMed Web of Science ®Google Scholar
• Heerema N A, Arthur D C, Sather H, et al. Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakoint on outcome: A report of the Childrens Cancer Group. Blood 1994; 83: 2274–2284
   PubMed Web of Science ®Google Scholar
• Lampert F, Harbott J, Ludwig W-D, et al. Acute leukemia with chromosome translocation (4;11): 7 new patients and analysis of 71 cases. Blut 1987; 54: 325–335
   PubMedGoogle Scholar
• Gu Y, Nakamura T, Alder H, et al. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell 1992; 71: 701–708
   PubMed Web of Science ®Google Scholar
• Domer P H, Fakharzadeh S S, Chen C-S, et al. Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product. Proc Natl Acad Sci USA 1993; 90: 7884–7888
   PubMed Web of Science ®Google Scholar
• Morrissey J, Tkachuk D C, Milatovich A, et al. A serine/prolinerich protein is fused to HRX in t(4;11) acute leukemias. Blood 1993; 81: 1124–1131
   PubMed Web of Science ®Google Scholar
• Bigner S H, Mark J, Ballard D E, et al. Chromosomal evolution in malignant gliomas starts with specific and usually numerical deviations. Cancer Genet Cytogenet 1986; 22: 121–135
   PubMed Web of Science ®Google Scholar
• Cowan J M, Halaban R, Francke U. Cytogenetic analysis of melanocytes from premalignant nevi and melanomas. J Natl Cancer Inst 1988; 80: 1159–1164
   PubMed Web of Science ®Google Scholar
• Lukeis R, Irving L, Garson M. Cytogenetics of non-small cell lung cancer. Analysis of consistent non-random abnormalities. Genes Chromos Cancer 1990; 2: 116–124
   PubMed Web of Science ®Google Scholar
• Chilcote R R, Brown E, Rowley J D. Lymphoblastic leukemia with lymphomatous features associated with abnormalities of the short arm of chromosome 9. N Engl J Med 1985; 313: 286–292
   PubMed Web of Science ®Google Scholar
• Laï J L, Fenaux P, Pollet J P, et al. Acute lymphocytic leukemia with 9p anomalies. A report of four additional cases and review of the literature. Cancer Genet Cytogenet 1988; 33: 99–109
   PubMed Web of Science ®Google Scholar
• Carroll A J, Castleberry R P, Crist W M. Lack of association between abnormalities of the chromosome 9 short arm and either “lymphomatous” features or T cell phenotype in childhood acute lymphocytic leukemia. Blood 1987; 69: 735–738
   PubMed Web of Science ®Google Scholar
• Murphy S B, Raimondi S C, Rivera G K, et al. Nonrandom abnormalities of chromosome 9p in childhood acute lymphoblastic leukemia: association with high-risk clinical features. Blood 1989; 74: 409–415
   PubMed Web of Science ®Google Scholar
• Kamb A, Shattuck-Eidens D, Eeles R, et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Science 1994; 264: 436–440
   PubMed Web of Science ®Google Scholar
• Serrano M, Harmon G J, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366: 704–707
   PubMed Web of Science ®Google Scholar
• Nobori T, Miura K, Wu D J, et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994; 368: 753–756
   PubMed Web of Science ®Google Scholar
• Takeuchi S, Bartram C R, Seriu T, et al. Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/ MTS1/TNK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Blood 1995; 86: 755–760
   PubMed Web of Science ®Google Scholar
• Rasool O, Heyman M, Brandter L B, et al. p15ink4B and p16ink4 gene inactivation in acute lymphocytic leukemia. Blood 1995; 85: 3431–3436
   PubMed Web of Science ®Google Scholar
• Hebert J, Cayuela J M, Berkeley J, et al. Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias. Blood 1995; 84: 4038–4044
   Web of Science ®Google Scholar
• Szczylik C, Sikorski T, Nicolaides N C, et al. Selective inhibition of leukemia cell proliferatin by bcr-abl antisense oligodeoxynucleotides. Science 1991; 253: 562–565
   PubMed Web of Science ®Google Scholar